Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

Predictive Value of the Platelet-To-Lymphocyte Ratio in Diagnosis of Prostate Cancer

(2015) Ozgur Haki Yuksel et al.   Asian Pacific Journal of Cancer Prevention

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio

(2015) Mehmet Kaynar et al.   Cancer Biomarkers

Inflammation and prostate cancer: friends or foe?

(2015) Gianluigi Taverna et al.   INFLAMMATION RESEARCH

Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy

(2015) Tanja Langsenlehner et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients

(2015) Tanja Langsenlehner et al.   WORLD JOURNAL OF UROLOGY

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status

(2014) Shao Hui Huang et al.   CANCER

Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

(2014) A. J. Templeton et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

(2014) Sylvia Adams et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

(2013) M Stotz et al.   BRITISH JOURNAL OF CANCER

Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

(2013) P Fox et al.   BRITISH JOURNAL OF CANCER

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

(2013) Axel Heidenreich et al.   EUROPEAN UROLOGY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

(2013) Axel Heidenreich et al.   EUROPEAN UROLOGY

Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer

(2012) Hyuk-Chan Kwon et al.   BIOMARKERS

A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)

(2012) David J. Pinato et al.   JOURNAL OF HEPATOLOGY

Low serum neutrophil count predicts a positive prostate biopsy

(2012) K Fujita et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer

(2011) Viren Asher et al.   Clinical & Translational Oncology

The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

Prostate cancer and inflammation: the evidence

(2011) Karen S Sfanos et al.   HISTOPATHOLOGY

Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer

(2011) De-shen Wang et al.   TUMOR BIOLOGY

Comparison of the Prognostic Value of Tumour- and Patient-Related Factors in Patients Undergoing Potentially Curative Resection of Oesophageal Cancer

(2011) Sumanta Dutta et al.   WORLD JOURNAL OF SURGERY

Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity

(2009) Sheng Zheng et al.   CANCER SCIENCE

Platelet-derived microparticles promote invasiveness of prostate cancer cellsviaupregulation of MMP-2 production

(2008) Olga Dashevsky et al.   INTERNATIONAL JOURNAL OF CANCER